Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 14/20 | 0.58 |
| ▸ | ABCB1 | P08183 | 9/20 | 0.58 |
| ▸ | ABCC1 | P33527 | 4/20 | 0.51 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.47 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.47 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.47 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.47 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MYC | P01106 | 1/20 | 0.44 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19939322 | 0.93 | ABCG2 (0.55) | ABCG2ABCB1ABCC1GABRA1GABRG2 | |
| SCHEMBL25872004 | 0.92 | ABCG2 (0.51) | ABCG2ABCB1ABCC1GABRA1GABRG2 | |
| SCHEMBL25872182 | 0.92 | ABCG2 (0.61) | ABCG2ABCB1ABCC1GABRA1GABRG2 | |
| SCHEMBL19939320 | 0.92 | ABCG2 (0.54) | ABCG2ABCB1ABCC1GABRA1GABRG2 | |
| SCHEMBL27369379 | 0.92 | ABCG2 (0.54) | ABCG2ABCB1ABCC1GABRA1GABRG2 | |
| SCHEMBL25872054 | 0.91 | ABCG2 (0.50) | ABCG2ABCB1ABCC1GABRA1GABRG2 | |
| SCHEMBL31663591 | 0.91 | ABCG2 (0.62) | ABCG2ABCB1ABCC1GABRA1GABRG2 | |
| SCHEMBL31643600 | 0.90 | ABCG2 (0.52) | ABCG2ABCB1ABCC1GABRA1GABRG2 | |
| SCHEMBL31463139 | 0.90 | ABCG2 (0.52) | ABCG2ABCB1ABCC1GABRA1GABRG2 | |
| SCHEMBL31463137 | 0.90 | ABCG2 (0.52) | ABCG2ABCB1ABCC1GABRA1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212141-A1 | Compound, Intermediate of the Compound, Process for Preparing the Compound, Organic Semiconducting Material Comprising the Compound, Organic Electronic Device Comprising the Same, and Display Device and Lighting Device Comprising the Same | NOVALED GMBH (DE) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212141-A1 | Compound, Intermediate of the Compound, Process for Preparing the Compound, Organic Semiconducting Material Comprising the Compound, Organic Electronic Device Comprising the Same, and Display Device and Lighting Device Comprising the Same | AOX1, ICMT, OCIAD2 | ABCG2 3068/4885ABCB1 2820/4885ABCC1 4486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.